Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin

Int J Nanomedicine. 2019 Oct 16:14:8235-8249. doi: 10.2147/IJN.S194352. eCollection 2019.

Abstract

Background: The effective induction of an antigen-specific T cell immune response through dendritic cell activation is one of the key goals of tumor immunotherapy.

Methods: In this study, efficient antigen-delivery carriers using silica-coated magnetic nanoparticles were designed and, their antigen-specific T cell immune response through dendritic cell activation investigated.

Results: The results showed that the silica-coated magnetic nanoparticles with conjugated ovalbumin enhanced the production of cytokines and antigen uptake in bone marrow-derived dendritic cells. Also, this induced an antigen-specific cytotoxic T lymphocyte (CTL) immune response and activated antigen-specific Th1 cell responses, including IL-2 and IFN-γ production and proliferation. We proved that the immune-stimulatory effects of silica-coated magnetic nanoparticles with conjugated ovalbumin were efficient in inhibiting of tumor growth in EG7-OVA (mouse lymphoma-expressing ovalbumin tumor-bearing mice model).

Conclusion: Therefore, the silica-coated magnetic nanoparticles with conjugated ovalbumin are expected to be useful as efficient anti-cancer immunotherapy agents.

Keywords: CD4+ T cell; CD8+ T cell; EG-7; antigen-delivery systems; dendritic cell; ovalbumin; silica-coated magnetic nanoparticles.

MeSH terms

  • Animals
  • Antigens / administration & dosage
  • Chickens
  • Cytokines / biosynthesis
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • Female
  • Immunity
  • Immunotherapy*
  • Magnetite Nanoparticles / chemistry*
  • Magnetite Nanoparticles / toxicity
  • Mice, Inbred C57BL
  • Neoplasms / immunology*
  • Neoplasms / therapy*
  • Ovalbumin / chemistry*
  • Silicon Dioxide / chemistry*

Substances

  • Antigens
  • Cytokines
  • Magnetite Nanoparticles
  • Silicon Dioxide
  • Ovalbumin